Title |
An Update on Kaposi’s Sarcoma: Epidemiology, Pathogenesis and Treatment
|
---|---|
Published in |
Dermatology and Therapy, November 2016
|
DOI | 10.1007/s13555-016-0152-3 |
Pubmed ID | |
Authors |
Paul Curtiss, Lauren C. Strazzulla, Alvin E. Friedman-Kien |
Abstract |
Kaposi's sarcoma is an angioproliferative neoplasm which has undergone considerable epidemiologic change since the original description by Moritz Kaposi in the late 1800s. This opportunistic neoplasm gained widespread notoriety within the US during the height of the AIDS epidemic, where it was frequently found co-occurring with opportunistic infections. With the advent of modern antiretroviral therapies, as well as an increasing number of individuals on immunosuppression for autoimmune disease or organ transplantation, the landscape of the immunocompromised individual has changed. It is now important for clinicians to be mindful of Kaposi's sarcoma manifesting in a growing variety of clinical contexts. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 2% |
Unknown | 65 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 12% |
Student > Bachelor | 8 | 12% |
Student > Doctoral Student | 7 | 11% |
Student > Postgraduate | 6 | 9% |
Student > Ph. D. Student | 5 | 8% |
Other | 7 | 11% |
Unknown | 25 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 36% |
Immunology and Microbiology | 5 | 8% |
Nursing and Health Professions | 4 | 6% |
Agricultural and Biological Sciences | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Other | 1 | 2% |
Unknown | 28 | 42% |